Stereotaxis to Present at Cowen 5th Annual FutureHealth Conference
18 juin 2020 09h05 HE
|
Stereotaxis, Inc.
ST. LOUIS, June 18, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David...
Pioneering Efforts in TeleRobotic Surgery Focus of Webcast Symposium on June 20th
10 juin 2020 09h00 HE
|
Stereotaxis, Inc.
New Leadership Council Announced to Advance Adoption of TeleRoboticsFirst Bi-Directional TeleRobotic Surgery Broadcast LiveST. LOUIS, June 10, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the...
Stereotaxis Robotic Technology Now Referenced In Over 400 Scientific Publications
02 juin 2020 09h00 HE
|
Stereotaxis, Inc.
Over 400 scientific publications now document clinical benefits of Stereotaxis robotic technologyMost recent publication reviews outcomes of 1,003 consecutive robotic procedures at a single center ...
Stereotaxis Announces $15 Million Common Stock Financing
26 mai 2020 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, May 26, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it has...
Stereotaxis Reports 2020 First Quarter Financial Results
05 mai 2020 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, May 05, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results...
Stereotaxis to Report First Quarter 2020 Financial Results on May 5, 2020
30 avr. 2020 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, April 30, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will...
Stereotaxis Reports 2019 Full Year Financial Results
10 mars 2020 08h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, March 10, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial...
Stereotaxis Earns FDA Clearance and Announces U.S. Launch of Genesis Robotic Magnetic Navigation System
06 mars 2020 08h05 HE
|
Stereotaxis, Inc.
ST. LOUIS, March 06, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today it has received...
Stereotaxis to Present at Three Investor Conferences in March
26 févr. 2020 16h06 HE
|
Stereotaxis, Inc.
ST. LOUIS, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David...
Stereotaxis to Report Fourth Quarter and Full Year 2019 Financial Results on March 10, 2020
26 févr. 2020 16h05 HE
|
Stereotaxis, Inc.
ST. LOUIS, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will...